Last reviewed · How we verify

NCT05301647

Mometasone Furoate Nasal Spray in Italian Children

Completed Last updated 31 March 2022
What this trial tests

trial testing Nasal cytology in Rhinitis, Allergic in 80 participants. Completed in 20 October 2021.

Timeline
20 June 2019
Primary endpoint
20 September 2021
20 October 2021

Quick facts

Lead sponsorUniversity of Campania Luigi Vanvitelli
StatusCompleted
Study typeOBSERVATIONAL
Enrollment80
Start date20 June 2019
Primary completion20 September 2021
Estimated completion20 October 2021
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Campania Luigi Vanvitelli

Who can join

Adults 4 to 12, any sex, with Rhinitis, Allergic or Nasal Allergy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective Seasonal allergic rhinitis (SAR) is a common disease in childhood and characterized by type 2 inflammation, bothersome symptoms, and impaired quality of life (QoL). Intranasal corticosteroids are effective medications in managing SAR patients. In addition, mometasone furoate nasal spray (MFNS) is a well-known therapeutic option. However, the literature provided no data about its effects in European children with SAR. Thus this study addressed this unmet need.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Nasal cytology

Trials testing the same drug.

Other recruiting trials for Rhinitis, Allergic

Currently open trials in the same condition.

Other University of Campania Luigi Vanvitelli trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05301647.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing